sj-docx-1-tan-10.1177_17562864231209240 – Supplemental material for Feasibility of home dose optimization of apomorphine sublingual film in Parkinson’s disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study

Kassubek, Jan; Stocchi, Fabrizio; Martinez, Ernest Balaguer; Pahwa, Rajesh; Ondo, William; Zhang, Yi; Bowling, Alyssa; Pappert, Eric; Isaacson, Stuart; Wu, Stacy

doi:10.25384/SAGE.24542349.v1

sj-docx-1-tan-10.1177_17562864231209240.docx (81.44 kB)

sj-docx-1-tan-10.1177_17562864231209240 – Supplemental material for Feasibility of home dose optimization of apomorphine sublingual film in Parkinson’s disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study

journal contribution

posted on 2023-11-10, 13:20 authored by Jan Kassubek, Fabrizio Stocchi, Ernest Balaguer Martinez, Rajesh Pahwa, William Ondo, Yi Zhang, Alyssa Bowling, Eric Pappert, Stuart Isaacson, Stacy Wu

Supplemental material, sj-docx-1-tan-10.1177_17562864231209240 for Feasibility of home dose optimization of apomorphine sublingual film in Parkinson’s disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study by Jan Kassubek, Fabrizio Stocchi, Ernest Balaguer Martinez, Rajesh Pahwa, William Ondo, Yi Zhang, Alyssa Bowling, Eric Pappert, Stuart Isaacson and Stacy Wu in Therapeutic Advances in Neurological Disorders